Figure 3
Subgroup analyses for the meta-analysis of the association between circulating galectin-3 at baseline and all-cause mortality risk after TAVR
(A) Subgroup analyses according to the adjustment of eGFR. (B) Subgroup analyses according to the adjustment of BNP or NT-proBNP. (C) Subgroup analyses according to the gelectin-3 measuring methods of ELFA or ELISA.